Advertisement

Cord Blood Clinical Processing, Cryopreservation, and Storage

  • Heidi Elmoazzen
  • Jelena L. HolovatiEmail author
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1257)

Abstract

Allogeneic umbilical cord blood (UCB) hematopoietic stem cell transplantation has become a crucial advancement in the treatment for a variety of diseases including hematopoietic and non-hematopoietic malignancies, BM failure syndromes, hemoglobinopathies, and metabolic and immunodeficiency disorders. It has been well documented that the success of UCB engraftment is tied to UCB banking processes, and now there are established guidelines for standardization of collection, banking, processing, and cryopreservation for unrelated UCB units with purpose of achieving consistent production of high quality placental and UCB units for administration. In 2011, Canada’s Ministry of Health has announced Canada’s first national, publicly funded umbilical cord blood bank, which aims to provide altruistic donations for unrelated allogeneic hematopoietic stem cell transplant. In this chapter, we describe specific protocols for clinical processing, cryopreservation, and storage of UCB used by the Canadian Blood Services National Public Umbilical Cord Blood Bank.

Key words

Umbilical cord blood (UCB) Hematopoietic stem cells (HSC) Transplant Cryopreservation Processing Cord blood bank 

Notes

References

  1. 1.
    Gluckman E, Broxmeyer HE, Auerbach AD, Friedman HS, Douglas GW, Devergie A, Esperou H, Thierry D, Socie G, Lehn P, Cooper S, English D, Kurtzberg J, Bard J, Boyse EA (1989) Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 321:1174–1178CrossRefGoogle Scholar
  2. 2.
    Ballen KK, Gluckman E, Broxmeyer HE (2013) Umbilical cord blood transplantation: the first 25 years and beyond. Blood 122:491–498CrossRefGoogle Scholar
  3. 3.
    Gratwohl A, Baldomero H (2009) Trends of hematopoietic stem cell transplantation in the third millennium. Curr Opin Hematol 16:420–426CrossRefGoogle Scholar
  4. 4.
    Ljungman P, Bregni M, Brune M, Cornelissen J, de Witte T, Dini G, Einsele H, Gaspar HB, Gratwohl A, Passweg J, Peters C, Rocha V, Saccardi R, Schouten H, Sureda A, Tichelli A, Velardi A, Niederwieser D, European Group for Blood and Marrow Transplantation (2010) Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Transplant 45:219–234CrossRefGoogle Scholar
  5. 5.
    Wagner JE (2010) Umbilical cord transplantation: state of the art 2010. Semin Hematol 47:1–2CrossRefGoogle Scholar
  6. 6.
    Worth AJJ, Booth C, Veys P (2013) Stem cell transplantation for primary immune deficiency. Curr Opin Hematol 20:501–508CrossRefGoogle Scholar
  7. 7.
    Cohen Y, Nagler A (2004) Umbilical cord blood transplantation – how, when and for whom? Blood Rev 18:167–179CrossRefGoogle Scholar
  8. 8.
    Emerson SG (1996) Ex vivo expansion of hematopoietic precursors, progenitors, and stem cells: the next generation of cellular therapeutics. Blood 87:3082–3088Google Scholar
  9. 9.
    Koegler G, Radke TF, Lefort A, Sensken S, Fischer J, Sorg RV, Wernet P (2003) Cytokine production and hematopoiesis supporting activity of cord blood–derived unrestricted somatic stem cells. Exp Hematol 33:573–583CrossRefGoogle Scholar
  10. 10.
    Kimura M, Gazitt Y, Cao X, Zhao X, Lansdorp PM, Aviv A (2010) Synchrony of telomere length among hematopoietic cells. Exp Hematol 38:854–859CrossRefGoogle Scholar
  11. 11.
    Piacibello W, Sanavio F, Severino A, Danè A, Gammaitoni L, Fagioli F, Perissinotto E, Cavalloni G, Kollet O, Lapidot T, Aglietta M (1999) Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells. Blood 93:3736–3749Google Scholar
  12. 12.
    Chen YH, Xu LP, Liu DH, Chen H, Zhang XH, Han W, Wang FR, Wang JZ, Wang Y, Huang XJ, Liu KY (2013) Comparative outcomes between cord blood transplantation and bone marrow or peripheral blood stem cell transplantation from unrelated donors in patients with hematologic malignancies: a single-institute analysis. Chin Med J 126:2499–2503Google Scholar
  13. 13.
    Locatelli F, Kabbara N, Ruggeri A, Ghavamzadeh A, Roberts I, Li CK, Bernaudin F, Vermylen C, Dalle JH, Stein J, Wynn R, Cordonnier C, Pinto F, Angelucci E, Socié G, Gluckman E, Walters MC, Rocha V (2013) Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling. Blood 122:1072–1078CrossRefGoogle Scholar
  14. 14.
    Zhang H, Chen J, Que W (2012) A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in acute leukemia patients. Biol Blood Marrow Transplant 18:1164–1173CrossRefGoogle Scholar
  15. 15.
    Metheny L, Caimi P, de Lima M (2013) Cord blood transplantation: can we make it better? Front Oncol 3(238):1–11Google Scholar
  16. 16.
    Flores-Guzmán P, Fernández-Sánchez V, Mayani H (2013) Concise review: ex vivo expansion of cord blood-derived hematopoietic stem and progenitor cells: basic principles, experimental approaches, and impact in regenerative medicine. Stem Cells Trans Med 2:830–838CrossRefGoogle Scholar
  17. 17.
    Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C, Goldman A, Kersey J, Krivit W, MacMillan ML, Orchard PJ, Peters C, Weisdorf DJ, Ramsay NK, Davies SM (2002) Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and non-malignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 100:1611–1618Google Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Canadian Blood Services National Public Cord Blood BankOttawaCanada
  2. 2.Canadian Blood Services Centre for InnovationEdmontonCanada
  3. 3.Department of Laboratory Medicine and PathologyUniversity of Alberta, Edmonton Clinic Health Academy 5-407EdmontonCanada

Personalised recommendations